Invention Grant
- Patent Title: Dispersible formulations of N-((R)-2,3-dihydroxypropoly)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
-
Application No.: US17177999Application Date: 2021-02-17
-
Publication No.: US11571402B2Publication Date: 2023-02-07
- Inventor: Kristin Patterson , Jiping Liu
- Applicant: SpringWorks Therapeutics Inc.
- Applicant Address: US CT Stamford
- Assignee: SpringWorks Therapeutics Inc.
- Current Assignee: SpringWorks Therapeutics Inc.
- Current Assignee Address: US CT Stamford
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: A61K31/167
- IPC: A61K31/167 ; A61K9/16 ; A61K9/20 ; A61K9/00
Abstract:
The present disclosure relates to dispersible pharmaceutical compositions comprising N—((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide, and, optionally, a pharmaceutically acceptable carrier.
Public/Granted literature
Information query
